Background: Bacteremia is a critical condition with high mortality that requires prompt detection to prevent progression to life-threatening sepsis. Traditional diagnostic approaches, such as blood cultures, are time-consuming. This limitation has encouraged the exploration of rapid prediction methodologies. Cellular Population Data (CPD), which provides detailed insights into white blood cell morphology and functionality, is a promising technique for the early detection of bacteremia.
Methods: This study applied machine learning models to analyze laboratory data from hospitalized patients at risk of bacteremia from three hospitals. Using complete blood count (CBC), differential count (DC), and CPD, collected at various time intervals, we trained two sets of artificial intelligence models: one trained using data from patients in the Emergency Department (ED) and another specifically designed for and trained using data from a hospitalized cohort. We evaluated the performance of both models by applying them to the same hospitalized population and comparing their outcomes.
Results: The study encompassed analysis of over 66,000 CBC samples. The model tailored for hospitalized patients exhibited superior performance in bacteremia prediction across all cohorts compared with the ED-model, achieving an area under the receiver operating characteristic curve (AUROC) of 0.772 in the validation cohort from China Medical University Hospital and 0.808 and 0.843 in two other hospital cohorts. Notably, nearly half of the top fifteen important features identified by shapely additive explanations values were CPD parameters, underscoring the pivotal role of CPD in predictive models for bacteremia.
Conclusions: Artificial intelligence models incorporating CPD data can accurately predict bacteremia in hospitalized patients. Models specifically trained on hospitalized patient data demonstrate enhanced performance over those based on ED data in predicting bacteremia occurrences. Future research must explore the clinical effects of these models, focusing on their potential to assist physicians in managing antibiotic use and patient health.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijmedinf.2025.105788 | DOI Listing |
Endocrinol Diabetes Metab
January 2025
Department of Endocrinology and Metabolism, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Objective: This study investigates the relationship between the albumin-to-creatinine ratio and diabetic retinopathy (DR) in US adults using NHANES data from 2009 to 2016. This study assesses the predictive efficacy of the urinary serum albumin-to-creatinine ratio (UACR/SACR Ratio) against traditional biomarkers such as the serum albumin-to-creatinine ratio (SACR) and urinary albumin-to-creatinine ratio (UACR) for evaluating DR risk. Additionally, the study explores the potential of these biomarkers, both individually and in combination with HbA1c, for early detection and risk stratification of DR.
View Article and Find Full Text PDFSemin Ophthalmol
January 2025
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Purposes: This meta-analysis aims to systematically analyze the efficacy of low-level red light (LRL) therapy for myopia control and prevention in children.
Methods: All the data were searched from the PubMed, EMBASE, and the Cochrane Library. The Cochrane Handbook was used to evaluate the quality of the included studies.
Paediatr Drugs
January 2025
Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China.
Background: This study aimed to provide a comprehensive review of adverse events (AEs) associated with factor Xa (FXa) inhibitors in pediatric patients.
Methods: We searched PubMed, Embase, Cochrane Library, ClinicalTrials.gov, and the European Union Clinical Trials Register for English-language records from the establishment of the database up to October 17, 2023.
Rheumatol Ther
January 2025
Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Jpn J Ophthalmol
January 2025
Department of Ophthalmology, Graduate of Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Purpose: To assess the efficacy and safety of PreserFlo MicroShunt (PMS) combined with mitomycin C in patients with medically treated primary open-angle glaucoma (POAG).
Study Design: A retrospective observational study.
Methods: The study examined 83 eyes from 83 patients with medically treated glaucoma surgery naive POAG.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!